Volume | 3,809 |
|
|||||
News | - | ||||||
Day High | 18.08 | Low High |
|||||
Day Low | 17.76 |
Etf Name | Etf Symbol | Market | Stock Type |
---|---|---|---|
ProShares UltraShort NASDAQ Biotechnology | BIS | NASDAQ | Exchange Traded Fund |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
17.86 | 17.76 | 18.08 | 18.59 |
Trades | Etfs Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
42 | 3,809 | 17.87 | 68,058 | - | 16.37 - 26.51 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
10:11:11 | 1 | 18.05 | USD |
ProShares UltraShort NASDAQ Biotechnology Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
4.37M | 246.00k | - | 99k | -3.51M | -14.27 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
News ProShares UltraShort NAS...
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
BIS Historical
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 20.70 | 20.74 | 17.76 | 19.42 | 4,717 | -2.63 | -12.72% |
1 Month | 19.14 | 21.10 | 17.76 | 19.73 | 7,867 | -1.07 | -5.60% |
3 Months | 18.10 | 21.10 | 16.37 | 18.44 | 7,698 | -0.0327 | -0.18% |
6 Months | 23.64 | 26.069 | 16.37 | 18.19 | 14,718 | -5.57 | -23.57% |
1 Year | 19.72 | 26.51 | 16.37 | 18.98 | 9,314 | -1.65 | -8.38% |
3 Years | 20.69 | 35.64 | 15.86 | 22.31 | 16,548 | -2.62 | -12.68% |
5 Years | 18.39 | 36.49 | 6.9501 | 16.37 | 56,520 | -0.3227 | -1.75% |
The investment seeks daily investment results that correspond to two times the inverse (-2x) of the daily performance of the Nasdaq Biotechnology Index. The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the funds investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified. |